Breast cancer patients resistant to endocrine therapy show decreased number of cytotoxic supressor cells and enhanced production of neoangiogenetic and immunosupressive factors

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F11%3A9726" target="_blank" >RIV/00216208:11110/11:9726 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/11:9726
Result on the web
<a href="http://dx.doi.org/10.4172/1948-5956.S2-005" target="_blank" >http://dx.doi.org/10.4172/1948-5956.S2-005</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Breast cancer patients resistant to endocrine therapy show decreased number of cytotoxic supressor cells and enhanced production of neoangiogenetic and immunosupressive factors
Original language description
Endocrine therapy is an essential modality in patients with hormone receptor positive breast cancer. Even with high therapeutic efficacy of first-line hormonal treatment, most patients with metastatic breast cancer will develop resistance.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
<a href="/en/project/NT11168" target="_blank" >NT11168: Transforming growth factor ? beta 1(TGF-beta 1) and a Vascular endotelial growth factor (VEGF) in the plasma of breast cancer patients resistent to antiestrogen therapy.</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)